Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography

K. S. Joseph, David S. Hage

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Sulfonylurea drugs are often prescribed as a treatment for type II diabetes to help lower blood sugar levels by stimulating insulin secretion. These drugs are believed to primarily bind in blood to human serum albumin (HSA). This study used high-performance affinity chromatography (HPAC) to examine the binding of sulfonylureas to HSA. Frontal analysis with an immobilized HSA column was used to determine the association equilibrium constants (Ka) and number of binding sites on HSA for the sulfonylurea drugs acetohexamide and tolbutamide. The results from frontal analysis indicated HSA had a group of relatively high-affinity binding regions and weaker binding sites for each drug, with average Ka values of 1.3 (±0.2) × 105 and 3.5 (±3.0) × 102 M-1 for acetohexamide and values of 8.7 (±0.6) × 104 and 8.1 (±1.7) × 103 M-1 for tolbutamide. Zonal elution and competition studies with site-specific probes were used to further examine the relatively high-affinity interactions of these drugs by looking directly at the interactions that were occurring at Sudlow sites I and II of HSA (i.e., the major drug-binding sites on this protein). It was found that acetohexamide was able to bind at both Sudlow sites I and II, with Ka values of 1.3 (±0.1) × 105 and 4.3 (±0.3) × 104 M-1, respectively, at 37 °C. Tolbutamide also appeared to interact with both Sudlow sites I and II, with Ka values of 5.5 (±0.2) × 104 and 5.3 (±0.2) × 104 M-1, respectively. The results provide a more quantitative picture of how these drugs bind with HSA and illustrate how HPAC and related tools can be used to examine relatively complex drug-protein interactions.

Original languageEnglish (US)
Pages (from-to)1590-1598
Number of pages9
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume878
Issue number19
DOIs
StatePublished - Jun 1 2010

Fingerprint

Affinity chromatography
Affinity Chromatography
Serum Albumin
Acetohexamide
Tolbutamide
Pharmaceutical Preparations
Binding Sites
Drug Interactions
Equilibrium constants
Type 2 Diabetes Mellitus
Medical problems
Blood Glucose
Proteins
Insulin
Blood
Association reactions

Keywords

  • Acetohexamide
  • Competition studies
  • Drug-protein binding
  • Frontal analysis
  • High-performance affinity chromatography
  • Human serum albumin
  • Sulfonylurea drugs
  • Tolbutamide
  • Zonal elution

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology

Cite this

@article{ebeba751d1574f8f91bed5b99bcc1ba6,
title = "Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography",
abstract = "Sulfonylurea drugs are often prescribed as a treatment for type II diabetes to help lower blood sugar levels by stimulating insulin secretion. These drugs are believed to primarily bind in blood to human serum albumin (HSA). This study used high-performance affinity chromatography (HPAC) to examine the binding of sulfonylureas to HSA. Frontal analysis with an immobilized HSA column was used to determine the association equilibrium constants (Ka) and number of binding sites on HSA for the sulfonylurea drugs acetohexamide and tolbutamide. The results from frontal analysis indicated HSA had a group of relatively high-affinity binding regions and weaker binding sites for each drug, with average Ka values of 1.3 (±0.2) × 105 and 3.5 (±3.0) × 102 M-1 for acetohexamide and values of 8.7 (±0.6) × 104 and 8.1 (±1.7) × 103 M-1 for tolbutamide. Zonal elution and competition studies with site-specific probes were used to further examine the relatively high-affinity interactions of these drugs by looking directly at the interactions that were occurring at Sudlow sites I and II of HSA (i.e., the major drug-binding sites on this protein). It was found that acetohexamide was able to bind at both Sudlow sites I and II, with Ka values of 1.3 (±0.1) × 105 and 4.3 (±0.3) × 104 M-1, respectively, at 37 °C. Tolbutamide also appeared to interact with both Sudlow sites I and II, with Ka values of 5.5 (±0.2) × 104 and 5.3 (±0.2) × 104 M-1, respectively. The results provide a more quantitative picture of how these drugs bind with HSA and illustrate how HPAC and related tools can be used to examine relatively complex drug-protein interactions.",
keywords = "Acetohexamide, Competition studies, Drug-protein binding, Frontal analysis, High-performance affinity chromatography, Human serum albumin, Sulfonylurea drugs, Tolbutamide, Zonal elution",
author = "Joseph, {K. S.} and Hage, {David S.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1016/j.jchromb.2010.04.019",
language = "English (US)",
volume = "878",
pages = "1590--1598",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",
number = "19",

}

TY - JOUR

T1 - Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography

AU - Joseph, K. S.

AU - Hage, David S.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Sulfonylurea drugs are often prescribed as a treatment for type II diabetes to help lower blood sugar levels by stimulating insulin secretion. These drugs are believed to primarily bind in blood to human serum albumin (HSA). This study used high-performance affinity chromatography (HPAC) to examine the binding of sulfonylureas to HSA. Frontal analysis with an immobilized HSA column was used to determine the association equilibrium constants (Ka) and number of binding sites on HSA for the sulfonylurea drugs acetohexamide and tolbutamide. The results from frontal analysis indicated HSA had a group of relatively high-affinity binding regions and weaker binding sites for each drug, with average Ka values of 1.3 (±0.2) × 105 and 3.5 (±3.0) × 102 M-1 for acetohexamide and values of 8.7 (±0.6) × 104 and 8.1 (±1.7) × 103 M-1 for tolbutamide. Zonal elution and competition studies with site-specific probes were used to further examine the relatively high-affinity interactions of these drugs by looking directly at the interactions that were occurring at Sudlow sites I and II of HSA (i.e., the major drug-binding sites on this protein). It was found that acetohexamide was able to bind at both Sudlow sites I and II, with Ka values of 1.3 (±0.1) × 105 and 4.3 (±0.3) × 104 M-1, respectively, at 37 °C. Tolbutamide also appeared to interact with both Sudlow sites I and II, with Ka values of 5.5 (±0.2) × 104 and 5.3 (±0.2) × 104 M-1, respectively. The results provide a more quantitative picture of how these drugs bind with HSA and illustrate how HPAC and related tools can be used to examine relatively complex drug-protein interactions.

AB - Sulfonylurea drugs are often prescribed as a treatment for type II diabetes to help lower blood sugar levels by stimulating insulin secretion. These drugs are believed to primarily bind in blood to human serum albumin (HSA). This study used high-performance affinity chromatography (HPAC) to examine the binding of sulfonylureas to HSA. Frontal analysis with an immobilized HSA column was used to determine the association equilibrium constants (Ka) and number of binding sites on HSA for the sulfonylurea drugs acetohexamide and tolbutamide. The results from frontal analysis indicated HSA had a group of relatively high-affinity binding regions and weaker binding sites for each drug, with average Ka values of 1.3 (±0.2) × 105 and 3.5 (±3.0) × 102 M-1 for acetohexamide and values of 8.7 (±0.6) × 104 and 8.1 (±1.7) × 103 M-1 for tolbutamide. Zonal elution and competition studies with site-specific probes were used to further examine the relatively high-affinity interactions of these drugs by looking directly at the interactions that were occurring at Sudlow sites I and II of HSA (i.e., the major drug-binding sites on this protein). It was found that acetohexamide was able to bind at both Sudlow sites I and II, with Ka values of 1.3 (±0.1) × 105 and 4.3 (±0.3) × 104 M-1, respectively, at 37 °C. Tolbutamide also appeared to interact with both Sudlow sites I and II, with Ka values of 5.5 (±0.2) × 104 and 5.3 (±0.2) × 104 M-1, respectively. The results provide a more quantitative picture of how these drugs bind with HSA and illustrate how HPAC and related tools can be used to examine relatively complex drug-protein interactions.

KW - Acetohexamide

KW - Competition studies

KW - Drug-protein binding

KW - Frontal analysis

KW - High-performance affinity chromatography

KW - Human serum albumin

KW - Sulfonylurea drugs

KW - Tolbutamide

KW - Zonal elution

UR - http://www.scopus.com/inward/record.url?scp=77952102923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952102923&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2010.04.019

DO - 10.1016/j.jchromb.2010.04.019

M3 - Article

C2 - 20435530

AN - SCOPUS:77952102923

VL - 878

SP - 1590

EP - 1598

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

IS - 19

ER -